| Literature DB >> 28199701 |
Xinying Zhou1, Fen Huang2, Lei Xu1, Zhanmin Lin3, Femke M S de Vrij4, Ane C Ayo-Martin4, Mark van der Kroeg4, Manzhi Zhao1, Yuebang Yin1, Wenshi Wang1, Wanlu Cao1, Yijin Wang1, Steven A Kushner4, Jean Marie Peron5,6, Laurent Alric6,7, Robert A de Man1, Bart C Jacobs8,9, Jeroen J van Eijk10, Eleonora M A Aronica11, Dave Sprengers1, Herold J Metselaar1, Chris I de Zeeuw3,12, Harry R Dalton13,14, Nassim Kamar7,15,16, Maikel P Peppelenbosch1, Qiuwei Pan1.
Abstract
Hepatitis E virus (HEV), as a hepatotropic virus, is supposed to exclusively infect the liver and only cause hepatitis. However, a broad range of extrahepatic manifestations (in particular, idiopathic neurological disorders) have been recently reported in association with its infection. In this study, we have demonstrated that various human neural cell lines (embryonic stem cell-derived neural lineage cells) induced pluripotent stem cell-derived human neurons and primary mouse neurons are highly susceptible to HEV infection. Treatment with interferon-α or ribavirin, the off-label antiviral drugs for chronic hepatitis E, exerted potent antiviral activities against HEV infection in neural cells. More importantly, in mice and monkey peripherally inoculated with HEV particles, viral RNA and protein were detected in brain tissues. Finally, patients with HEV-associated neurological disorders shed the virus into cerebrospinal fluid, indicating a direct infection of their nervous system. Thus, HEV is neurotropic in vitro, and in mice, monkeys, and possibly humans. These results challenge the dogma of HEV as a pure hepatotropic virus and suggest that HEV infection should be considered in the differential diagnosis of idiopathic neurological disorders.Entities:
Keywords: central nervous system; cerebrospinal fluid; hepatitis E virus; peripheral nervous system.
Mesh:
Substances:
Year: 2017 PMID: 28199701 DOI: 10.1093/infdis/jix079
Source DB: PubMed Journal: J Infect Dis ISSN: 0022-1899 Impact factor: 5.226